The global Pharmaceutical Contract Manufacturing/Contract Research Market is
anticipated to reach USD 238.3 billion by 2025, according to a new report by
Grand View Research, Inc. Impact on the volume of capacity that is required for
production due to of increasing expression levels is anticipated to influence
outsourcing industry. Increased cell densities as well as increase in
expression of each cell has led to the steady decline in the volume
requirement. The aforementioned fact provides the client with choices for in
selection from several CMOs, which was not the fact earlier.
The focus of large pharmaceutical companies
to strategically engage with a small number of preferred providers is a
meaningful departure from the procurement-based outsourcing. This was one of
the many approaches that the service industry had become accustomed to.
Expanding market for biosimilars and
biobetters is anticipated to pronounce the demand for contract development and
manufacturing support. Service providers that hold the potential of providing
cost as well as quality advantages are set to make inroads and grow at
tremendous pace in the forecast period.
However, as drug manufacturers are
increasing the investments with respect to production capabilities. This may
limit the potential growth of contract manufacturing services to traditional
customers thereby hampering industrial growth.
Browse Details of Report @
http://www.grandviewresearch.com/industry-analysis/pharmaceutical-contract-manufacturing-market
http://www.grandviewresearch.com/industry-analysis/pharmaceutical-contract-manufacturing-market
Further Key
Findings from the Report Suggest:
- Contract manufacturing services estimated to dominate the market
over research services
- These services are segmented on the basis of development of
different forms of formulations. Active Pharmaceutical Ingredient (API) /
Bulk drugs registered the largest share of revenue.
- Pharmaceutical companies prefer the outsourcing services for API
research and manufacture
- Factors supportive for this trend includes reduction in the cost of
production of APIs
- Active molecules from small companies are always acquired by the
big pharmaceutical companies
- The prominent entities focus on marketing rather than core competencies
of production of API in order to maintain presence
- Finished dose formulations are expected to register the fastest
growth in the coming years
- Contract research services for oncology dominated the market and
are anticipated to maintain the dominance in the coming years
- CMOs/CDMOs with the ability to establish facilities in emerging
countries are expected to drive growth
- Companies can position themselves for strong growth, given that
demand is expected to expand rapidly in the coming years
- The major countries include Brazil. Russia, India, and China as the
contract service sector is in its infancy in these regions
- Key players contributing in this market are AbbVie Contract
Manufacturing, Catalent, Grifols International, S.A., Baxter
BioPharma Solutions, Boehringer Ingelheim Biopharmaceuticals Gmbh, Dalton
Pharma Services, and Patheon.
- Companies are engaged in lifecycle management of small-molecule
drugs through the development of modified generics with uniquely enhanced
properties
- Increased competitiveness in the contract service sector is
anticipated to ultimately benefit the sector growth
About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment